DCGI grants emergency use nod to Covaxin, Corbevax, ZycovD for children

Published On 2022-04-27 12:13 GMT   |   Update On 2024-02-16 06:51 GMT

The Drugs Controller General of India (DCGI) on Tuesday approved three Covid vaccines for the restricted emergency use authorisation (EUA) for children of different age groups.

The DCGI gave the restricted emergency use authorisation to Bharat Biotech's Covaxin for children between the age of 6-12 years.

For more information, check out the full story on the link below:  

Coronavirus Vaccine: DCGI Grants Emergency Use Nod To Covaxin, Corbevax, ZycovD For Different Age Group Of Children

Full View
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News